MYXMayne Pharma Group Limited

MYX Stock Price, Valuation & Chart | Mayne Pharma Group Limited

$3.120-0.11 (-3.41%)

At close · 02 Sept 2026, 06:10 am

Sector: Healthcare Industry: Drug Manufacturers - General MYX intrinsic value MYX calculated fair value vs price Website

Overview Financials Dividends Ratios

MYX Historical price chart

MYX Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization253.49M

PE Ratio-6.24

EPS-0.5

Trading Volume269.89K

Today's High/Low3.33/3.12

Dividend Yield0.00

52 Week High/Low6.5/2.04

Shares Outstanding81.25M

MYX Financial Statement

MYX Analyst ratings

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Based on 1 analyst giving stock ratings to MYX in the past 3 months.

MYX Analysis & performance metrics

MYX Company profile

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United…

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract…

MYX Management team

Name

Position

Brenton Walter

Financial Controller

Lynn Sullivan

Executive Vice President & Leader of Women's Health

Daniel Moore

Executive Vice President of Specialty Products & Patient Solutions

Brant Schofield

Executive Vice President of Corporate Development

Erinn NathanielCTO

Director of Global Human Resources

Laura Loftus

Associate General Counsel & Company Secretary

Kimberly Parker J.D.

Executive Vice President & General Counsel

Shawn Patrick O'Brien B.ScCEO

Chief Executive Officer, MD & Director

Name

Position

Brenton Walter

Financial Controller

Lynn Sullivan

Executive Vice President & Leader of Women's Health

Daniel Moore

Executive Vice President of Specialty Products & Patient Solutions

Brant Schofield

Executive Vice President of Corporate Development

Erinn NathanielCTO

Director of Global Human Resources

Laura Loftus

Associate General Counsel & Company Secretary

Kimberly Parker J.D.

Executive Vice President & General Counsel

Shawn Patrick O'Brien B.ScCEO

Chief Executive Officer, MD & Director

Management Team

Brenton Walter

Financial Controller

Lynn Sullivan

Executive Vice President & Leader of Women's Health

Daniel Moore

Executive Vice President of Specialty Products & Patient Solutions

Brant Schofield

Executive Vice President of Corporate Development

Erinn NathanielCTO

Director of Global Human Resources

Laura Loftus

Associate General Counsel & Company Secretary

Kimberly Parker J.D.

Executive Vice President & General Counsel

Shawn Patrick O'Brien B.ScCEO

Chief Executive Officer, MD & Director

Management

Brenton Walter

Financial Controller

Lynn Sullivan

Executive Vice President & Leader of Women's Health

Daniel Moore

Executive Vice President of Specialty Products & Patient Solutions

Brant Schofield

Executive Vice President of Corporate Development

Erinn NathanielCTO

Director of Global Human Resources

Laura Loftus

Associate General Counsel & Company Secretary

Kimberly Parker J.D.

Executive Vice President & General Counsel

Shawn Patrick O'Brien B.ScCEO

Chief Executive Officer, MD & Director

Total 8 executives

MYX Frequently asked questions

What is Mayne Pharma Group Limited (MYX) Stock Price?

Current stock price of Mayne Pharma Group Limited (MYX) stock is $3.120. The stock price is -3.41% lower in the session. The intraday range can be seen from this page. Volume of Mayne Pharma Group Limited (MYX) stock is 269.89K.

Last updated at 02 Sept 2026, 06:10 am.

Why is the Mayne Pharma Group Limited (MYX) stock price going up or down today?

The stock price of Mayne Pharma Group Limited (MYX) can change with earnings, company news, and overall market sentiment. Mayne Pharma Group Limited operates in the Healthcare / Drug Manufacturers - General market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Mayne Pharma Group Limited stock expensive at its current price?

Whether Mayne Pharma Group Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for MYX on this page is -6.24. EPS on this page is -0.50. Compare those figures with peers and growth expectations before deciding if the current Mayne Pharma Group Limited price is justified.

How has the stock price of Mayne Pharma Group Limited (MYX) performed historically?

Historical performance for Mayne Pharma Group Limited (MYX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how MYX reacted to past earnings and market events.

Should I buy Mayne Pharma Group Limited (MYX) stock, at this price?

Buying Mayne Pharma Group Limited (MYX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.